What has to be true first
Mutual consent, protection against unwanted identification, and independent testing of each matching claim.
A proposed venture
The people most like you, found with consent.
Proposed. Not available today.
Most people who receive a serious diagnosis have never met anyone living with the same thing. For a rare condition there may be nobody in their city, or their country. The knowledge they most need, which is what the next ten years are like, exists only in the lives of strangers they have no way to find.
Families cannot always help. A child with an inherited syndrome may look more like other children with that syndrome, on the other side of the world, than like her own brother.
A proposed way to connect people with similar health experiences, using only information they choose to share. It begins with facial resemblance; health-related matching would need separate validation.
Nobody would be shown to anyone by default. Both people stay unidentified until both accept. Each match says honestly how close it is. Conversations are translated, because the nearest person like you may speak another language.
A resemblance is not a diagnosis, and it is not a family relation. Doppel would never tell someone what they have, and what two people say to each other is not medical advice. Any use that informs care would need evidence and validation first. None of it would be open to an insurer or an employer.
Doppel answers a question the record alone cannot: who else is like me? The record holds one person's history. Doppel, with consent, sets it beside others. That is how someone waiting years for a diagnosis might find the people who already have one, and how research might find the handful of patients, scattered across countries, that a study of a rare condition needs.
An iPhone app, now in development, that does this for faces alone. It begins there because resemblance in a face can be seen and tested, and because people with a visible difference often share more with each other than with those around them.
Mutual consent, protection against unwanted identification, and independent testing of each matching claim.
A clinical insight, a research question, an institution, or the experience of building one. We would like to hear what you could bring.